What are Progesterone receptor agonist drugs?

Progesterone receptor agonist drugs are pharmacologic agents that share a common mechanism (typically targeting Progesterone receptor (PR)). 0 are currently marketed, with 3 more in clinical development.

Progesterone receptor agonist

0 marketed 2 in Phase 3 1 in Phase 2

This page covers all Progesterone receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Progesterone receptor (PR), Progesterone receptor.

Targets

Progesterone receptor (PR) · Progesterone receptor

Phase 3 pipeline (2)

PGL4001, placebo, drug free period · PregLem SA · Obstetrics / Women's Health
PGL4001 is a selective progesterone receptor agonist that promotes uterine quiescence and prevents preterm labor.
PGL4001 matching placebo and iron · PregLem SA · Obstetrics/Gynecology
PGL4001 is a selective progesterone receptor agonist that promotes endometrial decidualization and suppresses uterine contractions to prevent miscarriage.

Phase 2 pipeline (1)

Etonogestrel-releasing IUS · Organon and Co · Women's Health
Etonogestrel-releasing IUS works by releasing a hormone that prevents ovulation and thickens cervical mucus to prevent sperm from reaching the egg.